Globus Medical Cash Flow Statement
NYSE: GMEDHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Globus Medical free cash flow
In fiscal 2025, Globus Medical generated $753.4 million of operating cash flow and spent $164.7 million on capital expenditures. That left free cash flow of $588.8 million, a free-cash-flow margin of 20.0% of revenue. Free cash flow was up 45.3% from the prior year's $405.2 million.
Globus Medical returned $300.5 million to shareholders through share repurchases, equal to 51% of free cash flow.
Summary generated from market data by MetaCap's automated system. Methodology
Globus Medical cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 537.87M | 102.98M | 122.87M | 190.17M | 149.19M | 102.28M | 155.21M | 156.47M | 107.35M | 104.34M |
| Net Income growth (YoY) | +422.28% | -16.19% | -35.39% | +27.47% | +45.86% | -34.10% | -0.81% | +45.76% | +2.88% | -7.49% |
| Depreciation & Amortization | 276.84M | 253.39M | 145.53M | 68.25M | 69.87M | 62.87M | 52.73M | 41.63M | 42.07M | 38.77M |
| Stock-Based Compensation | 49.78M | 54.19M | 52.74M | 32.81M | 30.59M | 27.07M | 26.09M | 21.90M | 14.69M | 11.38M |
| Change in Working Capital | -50.16M | -89.20M | -133.32M | -108.46M | -40.36M | -56.85M | -79.81M | -63.67M | -25.16M | -10.63M |
| Operating Cash Flow | 753.45M | 520.64M | 243.50M | 178.47M | 276.27M | 198.79M | 171.97M | 181.64M | 159.06M | 147.82M |
| Capital Expenditures | -164.68M | -115.43M | -78.27M | -74.05M | -56.90M | -63.66M | -70.75M | -59.70M | -51.30M | -40.91M |
| Investing Cash Flow | -355.01M | -176.05M | 302.97M | -110.36M | -375.94M | -117.32M | -140.28M | -193.03M | -111.28M | -162.74M |
| Share Repurchases | -300.45M | -85.79M | -225.56M | -144.49M | — | -104.67M | — | — | — | — |
| Debt Repaid | -449.99M | 0 | 0 | — | — | — | — | — | — | — |
| Financing Cash Flow | -679.16M | -27.70M | -231.82M | -109.96M | 54.15M | -38.66M | 24.44M | 32.57M | 1.63M | 470.00K |
| Net Change in Cash | -258.28M | 317.15M | 316.83M | -42.60M | -46.33M | 43.67M | 55.98M | 20.93M | 51.39M | -16.34M |
| Free Cash Flow | 588.77M | 405.21M | 165.22M | 104.42M | 219.38M | 135.13M | 101.22M | 121.95M | 107.75M | 106.91M |
This table shows 10 annual periods of Globus Medical's cash flow statement, from FY 2025 back to FY 2016, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow GMED's reporting calendar. What is a cash flow statement?